Global Psoriasis Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Psoriasis Therapeutics market size will reach US$ million by 2031.
Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Psoriasis Therapeutics Industry Forecast” looks at past sales and reviews total world Psoriasis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Psoriasis Therapeutics sales for 2025 through 2031. With Psoriasis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriasis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Psoriasis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Psoriasis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriasis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriasis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriasis Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriasis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Psoriasis Therapeutics Industry Forecast” looks at past sales and reviews total world Psoriasis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Psoriasis Therapeutics sales for 2025 through 2031. With Psoriasis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriasis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Psoriasis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Psoriasis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriasis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriasis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriasis Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriasis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- TNF Inhibitors
- PDE4 Inhibitors
- Interleukin Blockers
- Others
- Oral
- Parenteral
- Topical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma Inc.
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- F. Hofffmann-La Roche
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Valeant Pharmaceuticals International, Inc.
- Biocon Limited
- Eli Lilly and Company
- G & W Laboratories Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Therapeutics Market Size (2020-2031)
2.1.2 Psoriasis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Psoriasis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Psoriasis Therapeutics Segment by Type
2.2.1 TNF Inhibitors
2.2.2 PDE4 Inhibitors
2.2.3 Interleukin Blockers
2.2.4 Others
2.3 Psoriasis Therapeutics Market Size by Type
2.3.1 Psoriasis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Psoriasis Therapeutics Segment by Application
2.4.1 Oral
2.4.2 Parenteral
2.4.3 Topical
2.5 Psoriasis Therapeutics Market Size by Application
2.5.1 Psoriasis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
3 PSORIASIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Psoriasis Therapeutics Market Size Market Share by Player
3.1.1 Global Psoriasis Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Psoriasis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIASIS THERAPEUTICS BY REGION
4.1 Psoriasis Therapeutics Market Size by Region (2020-2025)
4.2 Global Psoriasis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriasis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Psoriasis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Psoriasis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Psoriasis Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Psoriasis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Psoriasis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Psoriasis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Psoriasis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Psoriasis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriasis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Psoriasis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Psoriasis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIASIS THERAPEUTICS MARKET FORECAST
10.1 Global Psoriasis Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Psoriasis Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Psoriasis Therapeutics Forecast
10.1.3 APAC Psoriasis Therapeutics Forecast
10.1.4 Europe Psoriasis Therapeutics Forecast
10.1.5 Middle East & Africa Psoriasis Therapeutics Forecast
10.2 Americas Psoriasis Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Psoriasis Therapeutics Forecast
10.2.2 Canada Market Psoriasis Therapeutics Forecast
10.2.3 Mexico Market Psoriasis Therapeutics Forecast
10.2.4 Brazil Market Psoriasis Therapeutics Forecast
10.3 APAC Psoriasis Therapeutics Forecast by Region (2026-2031)
10.3.1 China Psoriasis Therapeutics Market Forecast
10.3.2 Japan Market Psoriasis Therapeutics Forecast
10.3.3 Korea Market Psoriasis Therapeutics Forecast
10.3.4 Southeast Asia Market Psoriasis Therapeutics Forecast
10.3.5 India Market Psoriasis Therapeutics Forecast
10.3.6 Australia Market Psoriasis Therapeutics Forecast
10.4 Europe Psoriasis Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Psoriasis Therapeutics Forecast
10.4.2 France Market Psoriasis Therapeutics Forecast
10.4.3 UK Market Psoriasis Therapeutics Forecast
10.4.4 Italy Market Psoriasis Therapeutics Forecast
10.4.5 Russia Market Psoriasis Therapeutics Forecast
10.5 Middle East & Africa Psoriasis Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Psoriasis Therapeutics Forecast
10.5.2 South Africa Market Psoriasis Therapeutics Forecast
10.5.3 Israel Market Psoriasis Therapeutics Forecast
10.5.4 Turkey Market Psoriasis Therapeutics Forecast
10.6 Global Psoriasis Therapeutics Forecast by Type (2026-2031)
10.7 Global Psoriasis Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Psoriasis Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Information
11.1.2 Astellas Pharma Inc. Psoriasis Therapeutics Product Offered
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Astellas Pharma Inc. Main Business Overview
11.1.5 Astellas Pharma Inc. Latest Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Information
11.2.2 AstraZeneca plc Psoriasis Therapeutics Product Offered
11.2.3 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca plc Main Business Overview
11.2.5 AstraZeneca plc Latest Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Offered
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boehringer Ingelheim GmbH Main Business Overview
11.3.5 Boehringer Ingelheim GmbH Latest Developments
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Information
11.4.2 F. Hofffmann-La Roche Psoriasis Therapeutics Product Offered
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 F. Hofffmann-La Roche Main Business Overview
11.4.5 F. Hofffmann-La Roche Latest Developments
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Information
11.5.2 GlaxoSmithKline plc Psoriasis Therapeutics Product Offered
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline plc Main Business Overview
11.5.5 GlaxoSmithKline plc Latest Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Information
11.6.2 Merck & Co., Inc. Psoriasis Therapeutics Product Offered
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck & Co., Inc. Main Business Overview
11.6.5 Merck & Co., Inc. Latest Developments
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Information
11.7.2 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product Offered
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Valeant Pharmaceuticals International, Inc. Main Business Overview
11.7.5 Valeant Pharmaceuticals International, Inc. Latest Developments
11.8 Biocon Limited
11.8.1 Biocon Limited Company Information
11.8.2 Biocon Limited Psoriasis Therapeutics Product Offered
11.8.3 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Biocon Limited Main Business Overview
11.8.5 Biocon Limited Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Psoriasis Therapeutics Product Offered
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Information
11.10.2 G & W Laboratories Inc. Psoriasis Therapeutics Product Offered
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 G & W Laboratories Inc. Main Business Overview
11.10.5 G & W Laboratories Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Therapeutics Market Size (2020-2031)
2.1.2 Psoriasis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Psoriasis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Psoriasis Therapeutics Segment by Type
2.2.1 TNF Inhibitors
2.2.2 PDE4 Inhibitors
2.2.3 Interleukin Blockers
2.2.4 Others
2.3 Psoriasis Therapeutics Market Size by Type
2.3.1 Psoriasis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Psoriasis Therapeutics Segment by Application
2.4.1 Oral
2.4.2 Parenteral
2.4.3 Topical
2.5 Psoriasis Therapeutics Market Size by Application
2.5.1 Psoriasis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
3 PSORIASIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Psoriasis Therapeutics Market Size Market Share by Player
3.1.1 Global Psoriasis Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Psoriasis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIASIS THERAPEUTICS BY REGION
4.1 Psoriasis Therapeutics Market Size by Region (2020-2025)
4.2 Global Psoriasis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriasis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Psoriasis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Psoriasis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Psoriasis Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Psoriasis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Psoriasis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Psoriasis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Psoriasis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Psoriasis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriasis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Psoriasis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Psoriasis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIASIS THERAPEUTICS MARKET FORECAST
10.1 Global Psoriasis Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Psoriasis Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Psoriasis Therapeutics Forecast
10.1.3 APAC Psoriasis Therapeutics Forecast
10.1.4 Europe Psoriasis Therapeutics Forecast
10.1.5 Middle East & Africa Psoriasis Therapeutics Forecast
10.2 Americas Psoriasis Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Psoriasis Therapeutics Forecast
10.2.2 Canada Market Psoriasis Therapeutics Forecast
10.2.3 Mexico Market Psoriasis Therapeutics Forecast
10.2.4 Brazil Market Psoriasis Therapeutics Forecast
10.3 APAC Psoriasis Therapeutics Forecast by Region (2026-2031)
10.3.1 China Psoriasis Therapeutics Market Forecast
10.3.2 Japan Market Psoriasis Therapeutics Forecast
10.3.3 Korea Market Psoriasis Therapeutics Forecast
10.3.4 Southeast Asia Market Psoriasis Therapeutics Forecast
10.3.5 India Market Psoriasis Therapeutics Forecast
10.3.6 Australia Market Psoriasis Therapeutics Forecast
10.4 Europe Psoriasis Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Psoriasis Therapeutics Forecast
10.4.2 France Market Psoriasis Therapeutics Forecast
10.4.3 UK Market Psoriasis Therapeutics Forecast
10.4.4 Italy Market Psoriasis Therapeutics Forecast
10.4.5 Russia Market Psoriasis Therapeutics Forecast
10.5 Middle East & Africa Psoriasis Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Psoriasis Therapeutics Forecast
10.5.2 South Africa Market Psoriasis Therapeutics Forecast
10.5.3 Israel Market Psoriasis Therapeutics Forecast
10.5.4 Turkey Market Psoriasis Therapeutics Forecast
10.6 Global Psoriasis Therapeutics Forecast by Type (2026-2031)
10.7 Global Psoriasis Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Psoriasis Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Information
11.1.2 Astellas Pharma Inc. Psoriasis Therapeutics Product Offered
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Astellas Pharma Inc. Main Business Overview
11.1.5 Astellas Pharma Inc. Latest Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Information
11.2.2 AstraZeneca plc Psoriasis Therapeutics Product Offered
11.2.3 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca plc Main Business Overview
11.2.5 AstraZeneca plc Latest Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Offered
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boehringer Ingelheim GmbH Main Business Overview
11.3.5 Boehringer Ingelheim GmbH Latest Developments
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Information
11.4.2 F. Hofffmann-La Roche Psoriasis Therapeutics Product Offered
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 F. Hofffmann-La Roche Main Business Overview
11.4.5 F. Hofffmann-La Roche Latest Developments
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Information
11.5.2 GlaxoSmithKline plc Psoriasis Therapeutics Product Offered
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline plc Main Business Overview
11.5.5 GlaxoSmithKline plc Latest Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Information
11.6.2 Merck & Co., Inc. Psoriasis Therapeutics Product Offered
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck & Co., Inc. Main Business Overview
11.6.5 Merck & Co., Inc. Latest Developments
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Information
11.7.2 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product Offered
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Valeant Pharmaceuticals International, Inc. Main Business Overview
11.7.5 Valeant Pharmaceuticals International, Inc. Latest Developments
11.8 Biocon Limited
11.8.1 Biocon Limited Company Information
11.8.2 Biocon Limited Psoriasis Therapeutics Product Offered
11.8.3 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Biocon Limited Main Business Overview
11.8.5 Biocon Limited Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Psoriasis Therapeutics Product Offered
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Information
11.10.2 G & W Laboratories Inc. Psoriasis Therapeutics Product Offered
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 G & W Laboratories Inc. Main Business Overview
11.10.5 G & W Laboratories Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psoriasis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Psoriasis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of TNF Inhibitors
Table 4. Major Players of PDE4 Inhibitors
Table 5. Major Players of Interleukin Blockers
Table 6. Major Players of Others
Table 7. Psoriasis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Psoriasis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Psoriasis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Psoriasis Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Psoriasis Therapeutics Key Players Head office and Products Offered
Table 16. Psoriasis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Psoriasis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Psoriasis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Psoriasis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Psoriasis Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Psoriasis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Psoriasis Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Psoriasis Therapeutics
Table 41. Key Market Challenges & Risks of Psoriasis Therapeutics
Table 42. Key Industry Trends of Psoriasis Therapeutics
Table 43. Global Psoriasis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Psoriasis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Psoriasis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Psoriasis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Astellas Pharma Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 48. Astellas Pharma Inc. Psoriasis Therapeutics Product Offered
Table 49. Astellas Pharma Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Astellas Pharma Inc. Main Business
Table 51. Astellas Pharma Inc. Latest Developments
Table 52. AstraZeneca plc Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 53. AstraZeneca plc Psoriasis Therapeutics Product Offered
Table 54. AstraZeneca plc Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca plc Main Business
Table 56. AstraZeneca plc Latest Developments
Table 57. Boehringer Ingelheim GmbH Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 58. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Offered
Table 59. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Boehringer Ingelheim GmbH Main Business
Table 61. Boehringer Ingelheim GmbH Latest Developments
Table 62. F. Hofffmann-La Roche Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 63. F. Hofffmann-La Roche Psoriasis Therapeutics Product Offered
Table 64. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. F. Hofffmann-La Roche Main Business
Table 66. F. Hofffmann-La Roche Latest Developments
Table 67. GlaxoSmithKline plc Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 68. GlaxoSmithKline plc Psoriasis Therapeutics Product Offered
Table 69. GlaxoSmithKline plc Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. GlaxoSmithKline plc Main Business
Table 71. GlaxoSmithKline plc Latest Developments
Table 72. Merck & Co., Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 73. Merck & Co., Inc. Psoriasis Therapeutics Product Offered
Table 74. Merck & Co., Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Merck & Co., Inc. Main Business
Table 76. Merck & Co., Inc. Latest Developments
Table 77. Valeant Pharmaceuticals International, Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 78. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product Offered
Table 79. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Valeant Pharmaceuticals International, Inc. Main Business
Table 81. Valeant Pharmaceuticals International, Inc. Latest Developments
Table 82. Biocon Limited Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 83. Biocon Limited Psoriasis Therapeutics Product Offered
Table 84. Biocon Limited Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Biocon Limited Main Business
Table 86. Biocon Limited Latest Developments
Table 87. Eli Lilly and Company Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 88. Eli Lilly and Company Psoriasis Therapeutics Product Offered
Table 89. Eli Lilly and Company Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Eli Lilly and Company Main Business
Table 91. Eli Lilly and Company Latest Developments
Table 92. G & W Laboratories Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 93. G & W Laboratories Inc. Psoriasis Therapeutics Product Offered
Table 94. G & W Laboratories Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. G & W Laboratories Inc. Main Business
Table 96. G & W Laboratories Inc. Latest Developments
Table 1. Psoriasis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Psoriasis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of TNF Inhibitors
Table 4. Major Players of PDE4 Inhibitors
Table 5. Major Players of Interleukin Blockers
Table 6. Major Players of Others
Table 7. Psoriasis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Psoriasis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Psoriasis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Psoriasis Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Psoriasis Therapeutics Key Players Head office and Products Offered
Table 16. Psoriasis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Psoriasis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Psoriasis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Psoriasis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Psoriasis Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Psoriasis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Psoriasis Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Psoriasis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Psoriasis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Psoriasis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Psoriasis Therapeutics
Table 41. Key Market Challenges & Risks of Psoriasis Therapeutics
Table 42. Key Industry Trends of Psoriasis Therapeutics
Table 43. Global Psoriasis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Psoriasis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Psoriasis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Psoriasis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Astellas Pharma Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 48. Astellas Pharma Inc. Psoriasis Therapeutics Product Offered
Table 49. Astellas Pharma Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Astellas Pharma Inc. Main Business
Table 51. Astellas Pharma Inc. Latest Developments
Table 52. AstraZeneca plc Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 53. AstraZeneca plc Psoriasis Therapeutics Product Offered
Table 54. AstraZeneca plc Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca plc Main Business
Table 56. AstraZeneca plc Latest Developments
Table 57. Boehringer Ingelheim GmbH Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 58. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Offered
Table 59. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Boehringer Ingelheim GmbH Main Business
Table 61. Boehringer Ingelheim GmbH Latest Developments
Table 62. F. Hofffmann-La Roche Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 63. F. Hofffmann-La Roche Psoriasis Therapeutics Product Offered
Table 64. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. F. Hofffmann-La Roche Main Business
Table 66. F. Hofffmann-La Roche Latest Developments
Table 67. GlaxoSmithKline plc Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 68. GlaxoSmithKline plc Psoriasis Therapeutics Product Offered
Table 69. GlaxoSmithKline plc Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. GlaxoSmithKline plc Main Business
Table 71. GlaxoSmithKline plc Latest Developments
Table 72. Merck & Co., Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 73. Merck & Co., Inc. Psoriasis Therapeutics Product Offered
Table 74. Merck & Co., Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Merck & Co., Inc. Main Business
Table 76. Merck & Co., Inc. Latest Developments
Table 77. Valeant Pharmaceuticals International, Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 78. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product Offered
Table 79. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Valeant Pharmaceuticals International, Inc. Main Business
Table 81. Valeant Pharmaceuticals International, Inc. Latest Developments
Table 82. Biocon Limited Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 83. Biocon Limited Psoriasis Therapeutics Product Offered
Table 84. Biocon Limited Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Biocon Limited Main Business
Table 86. Biocon Limited Latest Developments
Table 87. Eli Lilly and Company Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 88. Eli Lilly and Company Psoriasis Therapeutics Product Offered
Table 89. Eli Lilly and Company Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Eli Lilly and Company Main Business
Table 91. Eli Lilly and Company Latest Developments
Table 92. G & W Laboratories Inc. Details, Company Type, Psoriasis Therapeutics Area Served and Its Competitors
Table 93. G & W Laboratories Inc. Psoriasis Therapeutics Product Offered
Table 94. G & W Laboratories Inc. Psoriasis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. G & W Laboratories Inc. Main Business
Table 96. G & W Laboratories Inc. Latest Developments
LIST OF FIGURES
Figure 1. Psoriasis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriasis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Psoriasis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Psoriasis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Psoriasis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Psoriasis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Psoriasis Therapeutics in Oral
Figure 11. Global Psoriasis Therapeutics Market: Oral (2020-2025) & ($ millions)
Figure 12. Psoriasis Therapeutics in Parenteral
Figure 13. Global Psoriasis Therapeutics Market: Parenteral (2020-2025) & ($ millions)
Figure 14. Psoriasis Therapeutics in Topical
Figure 15. Global Psoriasis Therapeutics Market: Topical (2020-2025) & ($ millions)
Figure 16. Global Psoriasis Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Psoriasis Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Psoriasis Therapeutics Value Market Share by Country in 2024
Figure 24. United States Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Psoriasis Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Psoriasis Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Psoriasis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Psoriasis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Psoriasis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriasis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Psoriasis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Psoriasis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Psoriasis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Psoriasis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Psoriasis Therapeutics in Oral
Figure 11. Global Psoriasis Therapeutics Market: Oral (2020-2025) & ($ millions)
Figure 12. Psoriasis Therapeutics in Parenteral
Figure 13. Global Psoriasis Therapeutics Market: Parenteral (2020-2025) & ($ millions)
Figure 14. Psoriasis Therapeutics in Topical
Figure 15. Global Psoriasis Therapeutics Market: Topical (2020-2025) & ($ millions)
Figure 16. Global Psoriasis Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Psoriasis Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Psoriasis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Psoriasis Therapeutics Value Market Share by Country in 2024
Figure 24. United States Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Psoriasis Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Psoriasis Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Psoriasis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Psoriasis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Psoriasis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Psoriasis Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Bioresorbable Polymers Market Growth 2025-2031
US$ 3,660.00
March 2025
128 pages
Global Vegetable (HPMC) Capsule Market Growth 2025-2031
US$ 3,660.00
January 2025
92 pages
Global Peptide Therapeutics Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
August 2025
140 pages
Global Examination Nitrile Gloves Market Growth 2025-2031
US$ 3,660.00
April 2025
151 pages
Global Digital Polymerase Chain Reaction (dPCR) Market Growth 2025-2031
US$ 3,660.00
January 2025
81 pages
